tiprankstipranks
Inovio Pharmaceuticals (INO)
:INO
US Market

Inovio Pharmaceuticals (INO) Income Statement

Compare
5,800 Followers

Inovio Pharmaceuticals Income Statement

Last quarter (Q3 2024), Inovio Pharmaceuticals's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q3, Inovio Pharmaceuticals's net income was $-25.17B. See Inovio Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 832.01K$ 10.26M$ 1.77M$ 7.41M$ 4.11M
Gross Profit
$ -2.67M$ 4.77M$ -2.96M$ -86.83M$ -83.91M
Operating Expenses
$ 144.77M$ 277.84M$ 302.99M$ 131.49M$ 115.22M
Depreciation and Amortization
$ 3.50M$ 5.50M$ 4.73M$ 4.63M$ 5.52M
EBITDA
$ -130.39M$ -270.90M$ -296.56M$ -149.56M$ -107.34M
Operating Income
$ -143.94M$ -267.57M$ -301.22M$ -124.08M$ -111.11M
Other Income/Expenses
$ 8.82M$ -10.08M$ -2.01M$ -38.81M$ -9.70M
Pretax Income
$ -135.12M$ -277.65M$ -303.22M$ -162.89M$ -120.81M
Net Income
$ -135.12M$ -287.66M$ -305.38M$ -215.09M$ -120.55M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -6.09$ -14.47$ -17.55$ -16.64$ -14.65
Diluted EPS
$ -6.09$ -14.47$ -17.55$ -16.64$ -14.65
Weighted Average Shares Outstanding
22.17M 19.89M 17.40M 12.93M 8.23M
Weighted Average Shares Outstanding (Diluted)
22.17M 19.89M 17.40M 12.93M 8.23M
Currency in USD

Inovio Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis